 Jeffrey SooHoo
Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glaucoma | 17 | 2023 | 201 | 3.930 |
Why?
| | Intraocular Pressure | 25 | 2023 | 275 | 2.410 |
Why?
| | Angiogenesis Inhibitors | 4 | 2018 | 213 | 1.750 |
Why?
| | Phacoemulsification | 10 | 2023 | 106 | 1.680 |
Why?
| | Glaucoma Drainage Implants | 5 | 2021 | 46 | 1.540 |
Why?
| | Trabeculectomy | 9 | 2022 | 65 | 1.500 |
Why?
| | Glaucoma, Open-Angle | 8 | 2023 | 94 | 1.480 |
Why?
| | Filtering Surgery | 5 | 2016 | 22 | 1.250 |
Why?
| | Glaucoma, Neovascular | 2 | 2015 | 10 | 0.920 |
Why?
| | Trabecular Meshwork | 5 | 2019 | 77 | 0.880 |
Why?
| | Lens Implantation, Intraocular | 4 | 2018 | 57 | 0.840 |
Why?
| | Tonometry, Ocular | 9 | 2021 | 83 | 0.800 |
Why?
| | Microfluidic Analytical Techniques | 2 | 2012 | 70 | 0.680 |
Why?
| | Eye Injuries | 2 | 2021 | 42 | 0.600 |
Why?
| | Vascular Endothelial Growth Factor A | 3 | 2015 | 496 | 0.560 |
Why?
| | Cell Separation | 2 | 2009 | 290 | 0.550 |
Why?
| | Leukocytes | 2 | 2009 | 272 | 0.540 |
Why?
| | Cataract | 6 | 2023 | 184 | 0.530 |
Why?
| | Perception | 1 | 2018 | 309 | 0.510 |
Why?
| | Laser Therapy | 2 | 2016 | 99 | 0.510 |
Why?
| | Antihypertensive Agents | 2 | 2016 | 428 | 0.500 |
Why?
| | Prosthesis Design | 1 | 2016 | 283 | 0.490 |
Why?
| | Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 103 | 0.480 |
Why?
| | Ocular Hypertension | 3 | 2022 | 61 | 0.470 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2015 | 154 | 0.460 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2014 | 55 | 0.460 |
Why?
| | Blepharoptosis | 1 | 2014 | 6 | 0.460 |
Why?
| | Patient Preference | 1 | 2016 | 164 | 0.450 |
Why?
| | Hyphema | 1 | 2013 | 4 | 0.450 |
Why?
| | Visual Acuity | 5 | 2019 | 272 | 0.440 |
Why?
| | Telangiectasis | 1 | 2013 | 6 | 0.430 |
Why?
| | Skin Diseases, Vascular | 1 | 2013 | 7 | 0.430 |
Why?
| | Laser Coagulation | 4 | 2023 | 53 | 0.420 |
Why?
| | Fluorescein Angiography | 1 | 2013 | 104 | 0.420 |
Why?
| | Recombinant Fusion Proteins | 1 | 2015 | 613 | 0.410 |
Why?
| | Orbital Neoplasms | 1 | 2012 | 19 | 0.410 |
Why?
| | Ophthalmologists | 2 | 2023 | 11 | 0.400 |
Why?
| | Anterior Chamber | 1 | 2012 | 19 | 0.400 |
Why?
| | Intravitreal Injections | 3 | 2018 | 45 | 0.390 |
Why?
| | Conjunctiva | 1 | 2012 | 50 | 0.390 |
Why?
| | Carcinoma | 1 | 2012 | 198 | 0.360 |
Why?
| | Stents | 4 | 2021 | 466 | 0.350 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2012 | 196 | 0.340 |
Why?
| | Uveitis | 2 | 2022 | 115 | 0.340 |
Why?
| | Dexamethasone | 1 | 2012 | 316 | 0.340 |
Why?
| | Surveys and Questionnaires | 4 | 2023 | 4595 | 0.330 |
Why?
| | Cataract Extraction | 2 | 2023 | 75 | 0.320 |
Why?
| | Humans | 40 | 2023 | 114043 | 0.320 |
Why?
| | Blood Component Removal | 1 | 2009 | 26 | 0.310 |
Why?
| | Ophthalmic Solutions | 3 | 2018 | 66 | 0.310 |
Why?
| | Erythrocytes | 1 | 2012 | 568 | 0.280 |
Why?
| | Ultrafiltration | 1 | 2007 | 27 | 0.280 |
Why?
| | Microfluidics | 1 | 2007 | 45 | 0.270 |
Why?
| | Ciliary Body | 2 | 2018 | 33 | 0.270 |
Why?
| | Leukocyte Count | 1 | 2007 | 292 | 0.260 |
Why?
| | Endoscopy | 2 | 2018 | 245 | 0.230 |
Why?
| | Prosthesis Implantation | 2 | 2018 | 138 | 0.230 |
Why?
| | Negotiating | 1 | 2023 | 27 | 0.210 |
Why?
| | Internship and Residency | 2 | 2023 | 920 | 0.210 |
Why?
| | Ophthalmology | 1 | 2023 | 75 | 0.200 |
Why?
| | Aged | 11 | 2021 | 18969 | 0.200 |
Why?
| | Weapons | 1 | 2021 | 8 | 0.180 |
Why?
| | Civil Disorders | 1 | 2021 | 7 | 0.180 |
Why?
| | Political Activism | 1 | 2021 | 9 | 0.180 |
Why?
| | Education, Medical, Graduate | 2 | 2023 | 366 | 0.180 |
Why?
| | Female | 15 | 2023 | 59325 | 0.170 |
Why?
| | Equipment Design | 3 | 2018 | 503 | 0.160 |
Why?
| | Treatment Outcome | 6 | 2022 | 9049 | 0.160 |
Why?
| | Male | 15 | 2023 | 55396 | 0.160 |
Why?
| | Aged, 80 and over | 6 | 2019 | 6306 | 0.160 |
Why?
| | Administration, Topical | 2 | 2016 | 137 | 0.160 |
Why?
| | Retrospective Studies | 10 | 2023 | 12521 | 0.150 |
Why?
| | Uveitis, Anterior | 1 | 2018 | 11 | 0.150 |
Why?
| | Glaucoma, Angle-Closure | 1 | 2018 | 16 | 0.150 |
Why?
| | Equipment Failure Analysis | 2 | 2009 | 132 | 0.140 |
Why?
| | Middle Aged | 9 | 2019 | 26605 | 0.140 |
Why?
| | Cross-Sectional Studies | 4 | 2023 | 4402 | 0.140 |
Why?
| | Adrenergic alpha-1 Receptor Antagonists | 1 | 2016 | 18 | 0.140 |
Why?
| | Infant | 4 | 2014 | 7943 | 0.140 |
Why?
| | Acrylic Resins | 1 | 2016 | 38 | 0.140 |
Why?
| | Lenses, Intraocular | 1 | 2016 | 42 | 0.130 |
Why?
| | Adult | 8 | 2020 | 30375 | 0.130 |
Why?
| | Cadaver | 1 | 2016 | 298 | 0.130 |
Why?
| | Vision Disorders | 1 | 2016 | 127 | 0.120 |
Why?
| | Drug Packaging | 1 | 2015 | 42 | 0.120 |
Why?
| | Blepharoplasty | 1 | 2014 | 5 | 0.110 |
Why?
| | Prospective Studies | 4 | 2021 | 6195 | 0.110 |
Why?
| | Eyelids | 1 | 2014 | 27 | 0.110 |
Why?
| | Rabbits | 2 | 2012 | 733 | 0.110 |
Why?
| | Oculomotor Muscles | 1 | 2014 | 38 | 0.110 |
Why?
| | Delivery of Health Care | 1 | 2020 | 828 | 0.110 |
Why?
| | Pilot Projects | 1 | 2018 | 1360 | 0.110 |
Why?
| | Accidents, Home | 1 | 2013 | 28 | 0.110 |
Why?
| | Livedo Reticularis | 1 | 2013 | 4 | 0.110 |
Why?
| | Postoperative Period | 3 | 2019 | 288 | 0.110 |
Why?
| | Iris | 1 | 2013 | 19 | 0.110 |
Why?
| | Sulfonamides | 1 | 2016 | 444 | 0.110 |
Why?
| | Young Adult | 3 | 2019 | 10444 | 0.110 |
Why?
| | Urothelium | 1 | 2012 | 33 | 0.100 |
Why?
| | Goblet Cells | 1 | 2012 | 16 | 0.100 |
Why?
| | Mitomycin | 1 | 2012 | 27 | 0.100 |
Why?
| | Quaternary Ammonium Compounds | 1 | 2012 | 44 | 0.100 |
Why?
| | Blister | 1 | 2012 | 43 | 0.100 |
Why?
| | Diffusion | 1 | 2012 | 119 | 0.100 |
Why?
| | Fatal Outcome | 1 | 2012 | 281 | 0.100 |
Why?
| | Neovascularization, Pathologic | 1 | 2013 | 280 | 0.090 |
Why?
| | Delayed-Action Preparations | 1 | 2012 | 158 | 0.090 |
Why?
| | Hemolysis | 1 | 2012 | 143 | 0.090 |
Why?
| | Adolescent | 4 | 2019 | 17800 | 0.090 |
Why?
| | Medication Adherence | 1 | 2015 | 531 | 0.090 |
Why?
| | Postoperative Complications | 1 | 2021 | 2122 | 0.090 |
Why?
| | Wound Healing | 1 | 2012 | 254 | 0.080 |
Why?
| | Collagen | 1 | 2012 | 414 | 0.080 |
Why?
| | Follow-Up Studies | 1 | 2018 | 4392 | 0.080 |
Why?
| | Phase Transition | 1 | 2009 | 25 | 0.080 |
Why?
| | Kinetics | 1 | 2012 | 1547 | 0.080 |
Why?
| | Inflammation | 1 | 2018 | 2464 | 0.070 |
Why?
| | Incidence | 1 | 2013 | 2314 | 0.070 |
Why?
| | Sex Factors | 2 | 2023 | 1706 | 0.070 |
Why?
| | Risk Assessment | 1 | 2014 | 2958 | 0.060 |
Why?
| | Infant, Newborn | 2 | 2014 | 5038 | 0.060 |
Why?
| | Colorado | 1 | 2013 | 4090 | 0.060 |
Why?
| | Salaries and Fringe Benefits | 1 | 2023 | 51 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 2272 | 0.050 |
Why?
| | Child, Preschool | 2 | 2013 | 9114 | 0.050 |
Why?
| | Dissent and Disputes | 1 | 2021 | 17 | 0.050 |
Why?
| | Crowding | 1 | 2021 | 36 | 0.040 |
Why?
| | Circadian Rhythm | 1 | 2023 | 356 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2007 | 3861 | 0.040 |
Why?
| | Health Surveys | 1 | 2021 | 441 | 0.040 |
Why?
| | Preoperative Period | 1 | 2019 | 102 | 0.040 |
Why?
| | Educational Status | 1 | 2020 | 408 | 0.040 |
Why?
| | Axial Length, Eye | 1 | 2018 | 9 | 0.040 |
Why?
| | Corneal Pachymetry | 1 | 2018 | 14 | 0.040 |
Why?
| | Exfoliation Syndrome | 1 | 2018 | 10 | 0.040 |
Why?
| | Pseudophakia | 1 | 2018 | 11 | 0.040 |
Why?
| | Histological Techniques | 1 | 2018 | 40 | 0.040 |
Why?
| | Refraction, Ocular | 1 | 2018 | 30 | 0.040 |
Why?
| | Sleep | 1 | 2023 | 631 | 0.040 |
Why?
| | Curriculum | 1 | 2023 | 813 | 0.040 |
Why?
| | Microscopy | 1 | 2018 | 125 | 0.030 |
Why?
| | Clinical Competence | 1 | 2023 | 882 | 0.030 |
Why?
| | United States | 2 | 2023 | 12137 | 0.030 |
Why?
| | Fibrosis | 1 | 2018 | 452 | 0.030 |
Why?
| | Child | 2 | 2013 | 18400 | 0.030 |
Why?
| | Lasers, Semiconductor | 1 | 2015 | 11 | 0.030 |
Why?
| | Medication Errors | 1 | 2015 | 88 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 2016 | 248 | 0.030 |
Why?
| | Animals | 2 | 2012 | 31565 | 0.030 |
Why?
| | Tissue Donors | 1 | 2012 | 314 | 0.020 |
Why?
| | Postoperative Care | 1 | 2012 | 223 | 0.020 |
Why?
| | Neoplasms | 1 | 1975 | 2086 | 0.010 |
Why?
| | Emigration and Immigration | 1 | 1975 | 45 | 0.010 |
Why?
| | Mexico | 1 | 1975 | 162 | 0.010 |
Why?
| | California | 1 | 1975 | 351 | 0.010 |
Why?
| | Risk | 1 | 1975 | 810 | 0.010 |
Why?
| | Uterine Cervical Neoplasms | 1 | 1975 | 213 | 0.010 |
Why?
| | Breast Neoplasms | 1 | 1975 | 1846 | 0.000 |
Why?
| | Lung Neoplasms | 1 | 1975 | 2159 | 0.000 |
Why?
|
|
SooHoo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|